Efficacy

Our Efficacy Studies are designed to assess the therapeutic potential of your compounds. We use advanced models and techniques, including non-invasive imaging, to track the progression of diseases like cancer or infections in real-time and measure the effectiveness of treatments.

Oncology

At ERBC, we offer comprehensive Oncology Efficacy Studies utilizing a variety of orthotopic and heterotopic murine tumor models, including glioblastoma, colorectal, pancreatic, ovarian, and myeloma models, to evaluate the therapeutic potential of cancer treatments. Our models are highly relevant, representing murine (syngeneic) or human (xenografted) tumor biology and providing critical data on tumor progression, metastasis, and therapeutic responses.

Learn more Learn more

Infectious diseases

We provide comprehensive efficacy studies in infectious diseases, utilizing the latest research models both for resistant SKAPE bacterial infections and airborne viruses to support drug development in this critical area, improving outcomes for patients facing novel or resistant infections.

Learn more Learn more

Osteo-Articular

Our Osteo-Articular efficacy studies provide valuable insights into the effectiveness of treatments for bone and joint diseases, helping to accelerate the development of therapies in this area. We also propose imaging-based services dedicated to evaluating Medical Device performance.

Learn more Learn more